Psoriasis Clinical Trials in Waltham, Massachusetts

4 studies are recruiting for psoriasis in Waltham, Massachusetts right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. The CorEvitas Psoriasis (PSO) Registry

    The primary objective of the CorEvitas Psoriasis Registry is to study the comparative safety of approved psoriasis therapies in a North American cohort of psoriasis subjects treated by dermatologists. This includes assessing the incidence and nature of adverse events of special interest, including …

    Stage
    Not phased
    Ages
    18 and older
    Site
    Research site, Waltham, Massachusetts
    Run by
    CorEvitas

    See if you can join NCT02707341 on ClinicalTrials.gov

  2. PPD™ CorEvitas™ Psoriasis (PSO) Rapid Response Non-Interventional Study

    This is a 16-week prospective, single-arm cohort, study of patients initiating advanced therapy for the treatment of moderate-to-severe plaque PSO. Eligible patients must be willing to be seen in-person by their treating physician for a Baseline visit (with first dose of the advanced therapy occurr…

    Stage
    Not phased
    Ages
    18 and older
    Site
    CorEvitas, LLC, Waltham, Massachusetts
    Run by
    CorEvitas

    See if you can join NCT07615712 on ClinicalTrials.gov

  3. PPD™ CorEvitas™ Psoriasis (PSO) Early Treatment Response Non-Interventional Study

    This is a 24-week prospective, single-arm cohort, study of patients initiating advanced therapy for the treatment of moderate-to-severe plaque PSO. Eligible patients must be willing to be seen in-person by their treating physician for a Baseline visit (with first dose of the advanced therapy occurr…

    Stage
    Not phased
    Ages
    18 and older
    Site
    CorEvitas, LLC, Waltham, Massachusetts
    Run by
    CorEvitas

    See if you can join NCT07648602 on ClinicalTrials.gov

  4. A Real-world Observational Study to Compare Effectiveness of Deucravacitinib Vs Apremilast in Adults With Plaque Psoriasis

    The purpose of this study is to understand the comparative effectiveness of deucravacitinib versus apremilast in adults with plaque psoriasis.

    Stage
    Not phased
    Ages
    18 and older
    Site
    Local Institution, Waltham, Massachusetts
    Run by
    Bristol-Myers Squibb

    See if you can join NCT05744466 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.